Peptides Derived From the Dependence Receptor ALK Are Proapoptotic for ALK-positive Tumors

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2015.102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides

Cancers
Cancer ResearchOncology
2019English

TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors

American Journal of Pathology
Forensic MedicinePathology
2000English

ALK (D5F3) CDx: An Immunohistochemistry Assay to Identify ALK-positive NSCLC Patients

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2018English

ALK Is a Critical Regulator of the MYC-signaling Axis in ALK Positive Lung Cancer

Oncotarget
Oncology
2018English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Prognostic Significance of NPM-ALK Fusion Transcript Overexpression in ALK-positive Anaplastic Large-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2007English

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Development of Anaplastic Lymphoma Kinase (ALK) Inhibitors and Molecular Diagnosis in ALK Rearrangement-Positive Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy